13F HOLDINGS REPORT
TFG Asset Management GP Ltd
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0000902664-26-001035
Total Value
$474.3M
Positions
31
Other Managers
3
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UIPATH INC | PATH | 10,450,000 | $171.3M | 36.11% |
| 2 | UIPATH INC | PATH | 4,132,044 | $67.7M | 14.28% |
| 3 | UIPATH INC | PATH | 2,867,956 | $47.0M | 9.91% |
| 4 | LYFT INC | LYFT | 1,000,000 | $19.4M | 4.08% |
| 5 | AUTOLUS THERAPEUTICS PLC | AUTL | 9,500,000 | $18.9M | 3.99% |
| 6 | SPRINKLR INC | CXM | 2,200,000 | $17.1M | 3.61% |
| 7 | KOLIBRI GLOBAL ENERGY INC | KGEI | 4,254,954 | $16.7M | 3.53% |
| 8 | WORKIVA INC | WK | 150,000 | $12.9M | 2.73% |
| 9 | KOLIBRI GLOBAL ENERGY INC | KGEI | 2,679,550 | $10.5M | 2.22% |
| 10 | ANNEXON INC | ANNX | 2,032,455 | $10.2M | 2.15% |
| 11 | PRAXIS PRECISION MEDICINES I | PRAX | 22,952 | $6.8M | 1.43% |
| 12 | CELLDEX THERAPEUTICS INC NEW | CLDX | 243,800 | $6.6M | 1.40% |
| 13 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 96,935 | $6.4M | 1.36% |
| 14 | PHARVARIS N V | PHVS | 194,612 | $5.4M | 1.14% |
| 15 | AXSOME THERAPEUTICS INC | AXSM | 26,934 | $4.9M | 1.04% |
| 16 | DYNE THERAPEUTICS INC | DYN | 247,997 | $4.9M | 1.02% |
| 17 | MBX BIOSCIENCES INC | MBX | 143,327 | $4.5M | 0.95% |
| 18 | RAPT THERAPEUTICS INC | 75382E208 | 131,770 | $4.5M | 0.94% |
| 19 | AGIOS PHARMACEUTICALS INC | AGIO | 162,018 | $4.4M | 0.93% |
| 20 | IMMUNOVANT INC | IMVT | 166,187 | $4.2M | 0.89% |
| 21 | ALKERMES PLC | ALKS | 141,172 | $3.9M | 0.83% |
| 22 | AMICUS THERAPEUTICS INC | FOLD | 260,771 | $3.7M | 0.78% |
| 23 | AMYLYX PHARMACEUTICALS INC | AMLX | 272,828 | $3.3M | 0.69% |
| 24 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 82,824 | $3.1M | 0.65% |
| 25 | NEKTAR THERAPEUTICS | NKTR | 69,287 | $2.9M | 0.62% |
| 26 | KRYSTAL BIOTECH INC | KRYS | 11,814 | $2.9M | 0.61% |
| 27 | MAPLIGHT THERAPEUTICS INC | MPLT | 164,525 | $2.9M | 0.61% |
| 28 | SILENCE THERAPEUTICS PLC | SLNCF | 365,369 | $2.2M | 0.47% |
| 29 | SNOWFLAKE INC | SNOW | 10,000 | $2.2M | 0.46% |
| 30 | ZEVRA THERAPEUTICS INC | ZVRA | 192,518 | $1.7M | 0.36% |
| 31 | AVADEL PHARMACEUTICALS PLC | G29687103 | 43,763 | $943,093 | 0.20% |